DPP-4 억제제의 췌장 외 영향 (심혈관 질환, 암, 췌장염 등) |
조은희 |
|
Effect of DPP-4 Inhibitors on the Cardiovascular System, Cancer and Pancreatitis. |
Eun Hee Cho |
Department of Internal Medicine, School of Medicine, Kangwon National University, Chuncheon, Korea. ehcho@kangwon.ac.kr |
|
Abstract |
Recently, dipeptidylpeptidase-4 (DPP-4) inhibitors have been widely used as a second-line therapy for type 2 diabetes because of their glucose-lowering efficacy, weight neutral effects and minimal hypoglycemia. However, there have been concerns regarding the lack of evidence of the long-term consequences of DPP-4 inhibitors on cardiovascular disease, acute pancreatitis and cancers; therefore, the effects of DPP-4 inhibitors on these three major diseases are reviewed in this article. A growing body of evidence demonstrates the cardioprotective role of DPP-4 inhibitors in animal and small clinical studies. However, clearly conflicting data regarding the effects of DPP-4 inhibitors on cancers and pancreatitis have been presented in preclinical and epidemiologic studies. The forthcoming long-term clinical studies on cardiovascular safety will provide more conclusive answers relating to the safety of DPP-4 inhibitors, including their effects on cancer and pancreatitis. |
Key Words:
Dipeptidyl-peptidase IV inhibitors, Cardiovascular diseases, Neoplasms, Pancreatitis |
|